NCT01664104 - A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting | Biotech Hunter

Enrollment

151

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Tocilizumab

Tocilizumab will be administered in routine clinical practice in accordance with local label. Study protocol does not specify/enforce any treatment regimen.

Trial Locations (24)

20052

Monza

20122

Milan

24127

Bergamo

25085

Gavardo

27100

Pavia

28100

Novara

37126

Verona

37134

Verona

40138

Bologna

44124

Cona (Ferrara)

46042

Castel Goffredo

50139

Florence

56100

Pisa

67100

Coppito

71100

Foggia

73042

Casarano (LE)

76121

Barletta

82037

Telese Terme

82100

Benevento

89133

Reggio Calabria

90146

Palermo

95124

Catania

95126

Catania

00128

Rome

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY